Intestinal Research

Inflammatory bowel diseases
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis: Shinta Mizuno, Keiko Ono, Yohei Mikami, Makoto Naganuma, Tomohiro Fukuda, Kazuhiro Minami, Tatsuhiro Masaoka, Soichiro Terada, Takeshi Yoshida, Keiichiro Saigusa, Norimichi Hirahara, Hiroaki Miyata, Wataru Suda, Masahira Hattori, Takanori Kanai; Intest Res. 2020;18(1):69-78. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00084
Web of Science 21 Crossref 19; Full text PubReader ePub PDF Supplementary Material

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases: Sang Hyoung Park, Jae Cheol Park, Milan Lukas, Martin Kolar, Edward V. Loftus, Jr; Intest Res. 2020;18(1):34-44. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.09147
Web of Science 19 Crossref 17; Full text PubReader ePub PDF

Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials: Toshifumi Hibi, Makoto Naganuma, Eisei Oda, Yoji Yamada, Yoshitomo Chujoh, Ryoichi Yoshihara, Mamoru Watanabe; Intest Res. 2020;18(1):56-68. Published online December 11, 2019; DOI: https://doi.org/10.5217/ir.2019.00064
Web of Science 7 Crossref 6; Full text PubReader ePub PDF

IBD
Nutritional approach as therapeutic manipulation in inflammatory bowel disease: Jin Young Yoon; Intest Res. 2019;17(4):463-475. Published online October 28, 2019; DOI: https://doi.org/10.5217/ir.2019.00078
Web of Science 4 Crossref 4; Full text PubReader ePub PDF

Inflammatory bowel diseases
Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study: Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm; Intest Res. 2019;17(4):496-503. Published online October 14, 2019; DOI: https://doi.org/10.5217/ir.2019.00050
Web of Science 16 Crossref 16; Full text PubReader ePub PDF

Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior: Rupa Banerjee, Partha Pal, Susan Hutfless, B Girish Ganesh, D Nageshwar Reddy; Intest Res. 2019;17(4):486-495. Published online August 6, 2019; DOI: https://doi.org/10.5217/ir.2018.00174
Web of Science 16 Crossref 16; Full text PubReader ePub PDF

Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?: Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon; Intest Res. 2020;18(1):85-95. Published online July 19, 2019; DOI: https://doi.org/10.5217/ir.2019.00055
Web of Science 4 Crossref 3; Full text PubReader ePub PDF Supplementary Material

Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis: Alissa Walsh, Lawrence Matini, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, John Geddes, Guy Goodwin, Gary Collins, Simon Travis, Michele Peters; Intest Res. 2019;17(3):365-374. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2018.00173
Web of Science 11 Crossref 12; Full text PubReader ePub PDF

IBD
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia: Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong, the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis; Intest Res. 2019;17(3):285-310. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00026
Web of Science 74 Crossref 76; Full text PubReader ePub PDF

Inflammatory bowel diseases
Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study: Toshifumi Hibi, Satoshi Motoya, Toshifumi Ashida, Souken Sai, Yukinori Sameshima, Shiro Nakamura, Atsuo Maemoto, Masahiro Nii, Barbara A Sullivan, Robert A. Gasser Jr, Yasuo Suzuki; Intest Res. 2019;17(3):375-386. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00141
Web of Science 15 Crossref 14; Full text PubReader ePub PDF

IBD
Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature: Yong-Sung Choi, Jong Kyu Kim, Wan Jung Kim, Mi-Jung Kim; Intest Res. 2019;17(2):273-277. Published online February 12, 2019; DOI: https://doi.org/10.5217/ir.2018.00122
Web of Science 4 Crossref 7; Full text PubReader ePub PDF

Inflammatory bowel diseases
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study: Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park; Intest Res. 2019;17(3):349-356. Published online February 8, 2019; DOI: https://doi.org/10.5217/ir.2018.00064
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

IBD
Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis: Shinji Okabayashi, Taku Kobayashi, Eiko Saito, Takahiko Toyonaga, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Junichi Tanaka, Keiji Yagisawa, Satoshi Kuronuma, Osamu Takeuchi, Toshifumi Hibi; Intest Res. 2019;17(2):218-226. Published online February 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00117
Web of Science 1 Crossref 2; Full text PubReader ePub PDF

Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients: Marcello Rabello Imbrizi, Daniela Oliveira Magro, Tirzah de Mendonça Lopes Secundo, Marlone Cunha-Silva, Paulo Gustavo Kotze, Ciro Garcia Montes, Jazon Romilson de Souza Almeida, Virgínia Lúcia Ribeiro Cabral; Intest Res. 2019;17(1):63-69. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00077
Web of Science 9 Crossref 9; Full text PubReader ePub PDF

Current new challenges in the management of ulcerative colitis: Tomohiro Fukuda, Makoto Naganuma, Takanori Kanai; Intest Res. 2019;17(1):36-44. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00126
Web of Science 42 Crossref 38; Full text PubReader ePub PDF

Search